RWM
ONC

Ritholtz Wealth Management’s BeOne Medicines Ltd ONC Stock Holding History

Ritholtz Wealth Management’s Portfolio ONC Stock Details ONC Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		– Sell
-860
Closed -$261K – 1287
2025
Q4 		$261K Sell
860
-144
-14% -$47.1K ﹤0.01% 962
2025
Q3 		$342K Buy
+1,004
New +$305K 0.01% 797

Other funds holding ONC

BBA
Baker Bros. Advisors New York $20B AUM 154.41% 1-Year Est. Return
Primecap Management
Primecap Management Pasadena, California $169B AUM 114.72% 1-Year Est. Return
Capital International Investors
Capital International Investors Los Angeles, California $484B AUM 34.9% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
Capital World Investors
Capital World Investors Los Angeles, California $846B AUM 46.74% 1-Year Est. Return
HA
HHLR Advisors Grand Cayman, Cayman Islands $832M AUM 32.38% 1-Year Est. Return
Citadel Advisors
Citadel Advisors Miami, Florida $875B AUM 40.91% 1-Year Est. Return
Temasek Holdings
Temasek Holdings Singapore $37.3B AUM 12.6% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return

Ritholtz Wealth Management's ONC Position: Q1 2026 in Review

Ritholtz Wealth Management sold out of BeOne Medicines Ltd (ONC) in Q1 2026, closing a stake of 860 shares — an estimated $261K sold.

Ritholtz Wealth Management first reported a position in ONC in Q3 2025 and held it in 2 quarters. The position peaked at $342K in Q3 2025. 282 funds tracked by Wall St. Rank hold ONC as of Q1 2026.

  • Ritholtz Wealth Management reported no remaining BeOne Medicines Ltd position as of Q1 2026 after selling out during the quarter.
  • Ritholtz Wealth Management sold 860 BeOne Medicines Ltd shares in Q1 2026, an estimated $261K.
  • Ritholtz Wealth Management first reported a position in BeOne Medicines Ltd in Q3 2025 and held it in 2 quarters.
  • Ritholtz Wealth Management's BeOne Medicines Ltd position peaked at $342K in Q3 2025.
  • 282 funds tracked by Wall St. Rank held BeOne Medicines Ltd as of Q1 2026.

Based on Ritholtz Wealth Management's 13F filing for Q1 2026, filed 20 Apr 2026.